OTC · Medical - Specialties

Carl Zeiss Meditec AG (CZMWF) Stock

$35.81 +5.23% OTC: CZMWF Healthcare

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery.

Valuation

MetricValue
Price$35.81
Market Cap$3.13B
P/E Ratio22.43
P/B Ratio1.27
P/S Ratio1.01
EPS (TTM)$1.60
52-Week High$55.75
52-Week Low$26.42
Dividend Yield1.76%

Financials & Margins

MetricValue
ROE4.27%
ROA2.69%
ROCE5.73%
Gross Margin50.81%
Operating Margin6.15%
Net Margin3.41%
Debt/Equity0.29
Current Ratio2.43

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.6B$1.9B$2.1B$2.1B$2.2B
Operating Profit$351.0M$397.0M$327.0M$121.0M$223.0M
Net Profit$236.0M$294.0M$290.0M$179.0M$141.0M
EPS$2.64$3.29$3.25$2.01$1.61
Op Margin21.3%20.9%15.7%5.9%10.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.4B$2.8B$3.0B$3.4B$3.4B
Total Liabilities$719.0M$793.0M$860.0M$1.3B$1.3B
Cash$7.0M$8.0M$11.0M$20.0M$27.0M
Borrowings$121.0M$128.0M$156.0M$151.0M$132.0M

Latest News

ZEISS Meditec Selects Atlas® System from Nirrin Technologies to Modernize Hyaluronic Acid Manufacturing Workflows Business Wire · Jun 30, 2026 ZEISS announces strategic collaboration with Envision Health Technologies to advance glaucoma care with virtual reality-based function testing CNW Group · Jun 18, 2026 ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 Units PR Newswire · Jun 17, 2026 ZEISS announces successful early implantations of the AT LUCIA toric 721P intraocular lens PR Newswire · Jun 11, 2026 Carl Zeiss says restructuring could affect up to 1,000 jobs MedTech Dive · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$363.0M$188.0M$251.0M$247.0M$246.0M
Investing Cash Flow$-141.0M$-231.0M$-225.0M$-565.0M$-153.0M
Financing Cash Flow$-227.0M$-12.0M$-37.0M$-126.0M$-66.0M
Net Cash Flow$1.0M$0$3.0M$10.0M$9.0M
Free Cash Flow$297.0M$106.0M$137.0M$95.0M$200.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.95
EV / EBITDA10.75
FCF Yield13.87%
Quick Ratio1.37
Interest Coverage4.19
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held59.23%
Institutions Held18.27%
Institutions Float Held44.80%
Institutional HolderSharesReport Date
Gilder, Gagnon, Howe & Co.11,7442023-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CLPBFColoplast A/S $64.00 +6.56% 44.09 $13.27B 2.42%
CZMWYCarl Zeiss Meditec AG $35.36 +0.60% 22.43 $3.10B 1.80%
ESLOFEssilorLuxottica S.A. $200.00 +2.04% 31.91 $91.92B 2.35%
HOCPFHOYA Corporation $159.57 +0.00% 32.45 $53.38B 1.34%
SAUHFStraumann Holding AG $130.77 +0.00% 45.53 $20.85B 1.24%

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and phacoemulsification and vitrectomy equipment; intraocular lenses for cataract surgery; and systems and consumables for laser eye surgery that include the VISUMAX femtosecond laser, which enables minimally invasive correction of vision defects using lenticular extraction, as well as digital products for the storage, analysis, and sharing of clinical data. The Microsurgery segment provides products and solutions for minimally invasive surgical treatments, including surgical visualization, interoperative radiotherapy, interoperative pathology, special surgical instruments, and digital solutions, as well as the ZEISS Tumor Workflow, a cross-product workflow solution. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG operates as a subsidiary of ZEISS Group.

Carl Zeiss Meditec AG is headquartered in DE.

Carl Zeiss Meditec AG (CZMWF) stock trades at $35.81 with a market capitalization of $3.13B. The stock is valued at a price-to-earnings (P/E) ratio of 22.43, price-to-book of 1.27, price-to-sales of 1.01. Over the past 52 weeks the stock has ranged between $26.42 and $55.75, and currently trades 35.8% below its 52-week high. It pays a dividend yielding 1.76%.

On profitability, Carl Zeiss Meditec AG generates a return on equity (ROE) of 4.27%, return on capital employed of 5.73%, an operating margin of 6.15%, a net profit margin of 3.41%.

Official website: www.zeiss.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides